Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry

Journal of Peptide Science

Volumn 2, Issue 1, 1996, Pages 66-72

  Zeng, Weiguang ^a,c   Jackson, David C ^b   Rose, Keith ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Gryphon Therapeutics   (United States)

Author keywords

MAPS; Pam3Cys; Polyoxime; Polypeptide vaccine

Indexed keywords

INFLUENZA VIRUS;

2,3 BIS(PALMITOYLOXY) 2 PROPYL 1 PALMITOYLCYSTEINE; 2,3-BIS(PALMITOYLOXY)-2-PROPYL-1-PALMITOYLCYSTEINE; AZETIDINE 2 CARBOXYLIC ACID; CYSTEINE; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; LIPOPROTEIN; POLYOXIMIC ACID; RECOMBINANT VACCINE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; DNA TEMPLATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; MOLECULAR WEIGHT; ORTHOMYXOVIRUS; PROTEIN CONFORMATION; SYNTHESIS;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; AZETIDINECARBOXYLIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; INFLUENZA VACCINES; LIPOPROTEINS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; ORTHOMYXOVIRIDAE; PROTEIN CONFORMATION; TEMPLATES, GENETIC; VACCINES, SYNTHETIC; VIRAL PROTEINS;

EID: 0029677802     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.51     Document Type: Article

References (31)

1. R. A. Lerner (1984). Antibodies of predetermined specificity in biology and medicine. Adv. Immunol. 36, 1-44.
2. M.-P. Schultze, C. Leclerc, M. Jolivet, F. Audibert and L. Chedid (1985). Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunol. 135, 2319-2322.
3. H. L. Niman, R. A. Houghten, L. E. Walker, R. A. Reisfeld, I. A. Wilson, J. M. Hogle and R. A. Lerner (1983). Generation of protein-reactive antibodies by short peptides is an event of high frequency. Implications for the structural basis of immune recognition. Proc. Natl. Acad. Sci. USA 80, 4949-4953.
4. J. P. Tam (1988). Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA 85, 5409-5413.
5. J.-P. Defoort, B. Nardelli, W. Huang and J. P. Tam (1992). A rational design of synthetic peptide vaccine with a built-in adjuvant. Int. J. Peptide Protein Res. 40, 214-221.
6. E. Wünsch, L. Moroder, G. Hübener, H.-J. Musiol, R. Von Grünigen, W. Göhring, R. Scharf and C. H. Schneider (1991). Fully synthetic immunogens. Int. J. Peptide Protein Res. 37, 90-102.
7. M. Mutter, G. G. Tuchscherer, C. Miller, K.-H. Altman, R. I. Carey, D. F. Wyss, A. M. Labhardt and J. E. Rivier (1992). Template-assembled synthetic proteins with four-helix-bundle topology. Total synthesis and conformational studies. J. Am. Chem. Soc. 114, 1463-1470.
8. J. P. Tam and J. C. Spetzler (1995). Chemoselective approaches to the preparation of peptide dendrimers and branched artificial proteins using unprotected peptides as building blocks. Biomed. Peptide Protein Nucleic Acids 1, 123-132.
9. K. Rose (1994). Facile synthesis of artificial proteins. J. Am. Chem. Soc. 116, 30-33.
10. M. Schnölzer and S. B. H. Kent (1992). Constructing proteins by dovetailing unprotected synthetic peptides: back-bone engineering HIV protease. Science 256, 221-225.
11. P. E. Dawson and S. B. H. Kent (1993). Convenient total synthesis of a 4-helix TASP molecule by chemoselective ligation. J. Am. Chem. Soc. 115, 7263-7266.
12. J. W. Drijfhout and W. Bloemhoff (1991). A new synthetic functionalized antigen carrier. Int. J. Peptide Protein Res. 37, 27-32.
13. C.-F. Liu and J. P. Tam (1994). Peptide segment ligation strategy without use of protecting groups. Proc. Natl. Acad. Sci. USA 91, 6584-6588.
14. C. Rao and J. P. Tam (1994). Synthesis of peptide dendrimer. J. Am. Chem. Soc. 116, 6975-6976.
15. J. Shao and J. P. Tam (1995). Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone, and thiazolidine linkages. J. Am. Chem. Soc. 117, 3893-3899.
16. J. C. Spetzler and J. P. Tam (1995). Unprotected peptides as building blocks for branched peptides and peptide dentrimers. Int. J. Peptide Protein Res. 45, 78-83.
17. P. E. Dawson, T. W. Muir, I. Clark-Lewis and S. B .H. Kent (1994). Synthesis of proteins by native chemical ligation. Science 266, 776-779.
18. K. Rose, W. Zeng, L. E. Brown and D. C. Jackson. A synthetic peptide based polyoxime vaccine construct of high purity and activity. Mol. Immunol., in press.
19. W. Zeng, K. Rose and D. C. Jackson in: Peptides 1994, H. L. S. Maia, Ed., pp. 855-856. ESCOM, Leiden. The Netherlands, 1995.
20. K.-H. Wiesmüller, G. Jung, D. Gillessen, C. Loffl, W. Bessler and T. Böltz (1991). The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. Immunology 72, 109-113.
21. K. Deres, H. Schild, K.-H. Wiesmüller, G. Jung and H.-G. Rammensee (1989). In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342, 561-564.
22. E. Wünsch and J. Jentsch (1964). Zur Darstellung von Hydroxyaminosäure-tert-butyläthern. Ber. dtsch. chem. Ges. 97, 2490-2496.
23. K.-H. Wiesmüller, W. Bessler and G. Jung (1983). Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. Hoppe-Seyler's Z. Physiol. Chem. 364, 593-596.
24. D. C. Jackson and L. E. Brown (1991). A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen. Peptide Res. 4, 114-124.
25. B. W. Bycroft, W. C. Chan, S. R. Chhabra and N. D. Hone (1993). A novel lysine-protection procedure for continuous flow solid phase synthesis of branched peptides. J. Chem. Soc. Chem. Commun, 778-779.
26. L. A. Vilaseca, K. Rose, R. Werlen, A. Meunier, R. E. Offord, C. L. Nichols and W. L. Scott (1993). Protein conjugates of defined structure. Synthesis and use of a new carrier molecule. Bioconj. Chem. 4, 515-520.
27. J. Metzger, K.-H. Wiesmüller, R. Schaude, W. G. Bessler and G. Jung (1991). Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. Int. J. Peptide Protein Res. 37, 46-57.
28. P. W. Banda, L. Nuwaysir and L. Chen in: Peptides: Chemistry, Structure and Biology, P. T. P. Kaumaya, Ed., ESCOM, Leiden, The Netherlands, In press.
29. H. F. Gärtner, K. Rose, R. Cotton, D. Timms, R. Camble and R. E. Offord in Peptides 1992, C. H. Schneider and A. N. Eberle. Eds., pp. 239-240. ESCOM, Leiden, The Netherlands 1993.
30. J. R. Broderson (1989). A retrospective review of lesions associated with the use of Freund's adjuvant. Lab. Anim. Sci. 39, 400-405.
31. A. Vitiello, G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. Lafond, L. Yuan, F. V. Chisari. J. Furze, R. Bartholomeuz and R. W. Chesnut (1995). Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. J. Clin. Invest. 95, 341-349.